Aerin reports positive results for VivAer
Aerin Medical, specialists in developing treatments for chronic nasal conditions, has published positive two-year follow-up data from the AERWAY trial…
All articles by Michelle Moore
Michelle Moore
Michelle Moore joined Medical Device Network in 2023 as a trainee healthcare reporter. With a background in medical science and economics, Michelle has experience working on medical and socioeconomic research projects. She is interested in molecular biology, personalised medicine and how artificial intelligence is changing the face of healthcare. Michelle holds a BSc in Biomedical Science and an MSc in Molecular Medicine, both from the University of Sheffield, as well as an MSc(Res) in Medicine and Economics from the University of St Andrews.
-
-
OneStudyTeam customers hit more than 7,000
The cloud-based patient enrolment management platform, StudyTeam, from the company OneStudyTeam, is being used by more than 4,000 clinical research…
-
Arthrosi wins $75m in Series D financing
Arthrosi Therapeutics, a biotechnology company specialising in gout treatment, has successfully secured $75m in Series D financing. Led by Guangrun…
-
Callidatas’ drug setanaxib shows promising results
Callidatas Therapeutics has released interim data from its proof-of-concept Phase II trial in patients with squamous cell carcinoma of the…
-
Skyelarke makes public significant changes to SkyePay
Skyelarke, the health technology company specialising in making clinical research accessible, has announced alterations to its patient payment technology SkyePay.…
-
Pulmatrix submits IND application for PUR3100
Pulmatrix has submitted an investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for PUR3100.…
-
Acasti appoints WuXi to conduct STRIVE-ON trial
Acasti Pharma, a late-stage biopharma company with drug candidates addressing rare and orphan diseases, has announced that WuXi Clinical Development…
-
Alphyn releases data from its Phase 2a trial of AB-101a
Alphyn Biologics has released new data from the first cohort of its Phase 2a clinical trial of AB-101a, a novel…
-
Celltrion presents infliximab data at ECCO Congress
Celltrion Healthcare presented new data at the 18th European Crohn’s and Colitis Organisation (ECCO) annual congress in Copenhagen, Denmark. The…
-
Cerecin presents findings from Phase II trial for tricaprilin
Cerecin, a biotechnology company that develops neurotherapeutics has presented its findings from a recent study of CER-0001 (tricaprilin), an investigational…